ABAnn-Sofie Backman

Ann-Sofie Backman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ann-Sofie Backman has a total of 101 co-authors. Here are the top co-authors by number of shared publications:

  • Paul Blomqvist

    Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

    4 shared publications
  • Johanna Adami

    Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

    3 shared publications
  • Magdalena Lagerlund

    Department of Medical Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada

    3 shared publications
  • Sophie Walton Bernstedt

    Division of Clinical Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden

    3 shared publications
  • Adrianna Haxhijaj

    Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden

    2 shared publications
  • Alexander Frank

    Dept. of Medicine, Ersta Hospital, Stockholm, Sweden

    2 shared publications

Latest Publications

  • Duodenal involvement in MUTYH-associated polyposis: findings from an international study and implications for endoscopic surveillance.

    by Becky Truscott, Imogen Bennett, Arron S. Lacey, Arthur S. Aelvoet, Angel Alonso Sanchez, M. Rosario Aznárez, Ann-Sofie Backman, Jan Bjork, Gabriel Capella, Susan K. Clark, et al.

    Objectives: This study aimed to better document incidence and progression of duodenal disease in MUTYH -associated polyposis (MAP). Methods: Incidences of duodenal cancer, and duodenal polyposis by age and genotype were assessed in individuals with genetically confirmed MAP. Results: At first endoscopy, 91/679 participants (13.4%) had duodenal adenoma(s) at a median age of 53 years (range 22 to 81 years). 439/679 participants had 1370 further endoscopies, over a median period of 6.3 years (range 1 month to 30 years). This included 365 without adenomas at first endoscopy, of whom 83 (22.7%) developed non-ampullary adenomas during follow-up at a median age of 53 years (range 29-76). Thirty-eight adenomas (5.5%) contained high-grade dysplasia (HGD), of which thirty-five had a known size and 20 (57.1%) of these were 10mm or smaller. Ampullary lesions were uncommon (31/679, 4.6%). Duodenal cancer was diagnosed in 5/679 participants (0.74%) at a median age of 65 years (range 47-83 years) and at a median of 12 months (range 9-24 months) following a surveillance endoscopy. At least four were located distally (in the third or fourth part). The cumulative incidences of duodenal adenomas and cancer at 70 years were 16.5-63.5%, depending on genotype, and 0.58%, respectively. Adenoma incidence was significantly higher in Y179C (hazard ratio 5.33 (2.94–9.67, <0.001) and E480X (4.07 (2.16–7.67), <0.001) than G396D homozygotes. Conclusions: Future clinical guidelines for MAP should consider genotype-specific recommendations for duodenal surveillance, the importance of assessing the distal duodenum (i.e. D3, D4) and polypectomy of all detectable adenomas.

  • Open Access

    Experiences of Transition to Adult Care Among Patients With Inflammatory Bowel Disease in Stockholm County. A Qualitative Study

    by Erik Florwald, Ann‐Sofie Backman, Petter Malmborg, Peter T. Schmidt, Hanna Augustsson Öfverström

    Background: Patients with childhood‐onset inflammatory bowel disease (IBD) more often present with severe disease phenotypes and are at increased risk of low school performance, later psychiatric disorders and low attachment to the labour market. The transition to adult care can be challenging, as it involves changes in care routines and relationships with healthcare providers. An unsuccessful transition can result in increased disease burden, increased loss to follow‐up and increased emotional stress for patients and parents. This study aimed to explore the experiences of transition to adult care among patients with childhood‐onset IBD and their parents, both before and after transfer and to identify key processes and influences shaping the transition process. Methods: Semi‐structured interviews were conducted with 15 patients (9 pre‐ and 6 post‐transfer) and 8 parents. The interview data were analysed using reflexive thematic analysis. Results: Four overarching themes were identified: developing autonomy through the transition , clarifying the unknown , shifting from familiar bonds to new connections and experiencing emotional strain during the transition . Pre‐transfer patients expressed concerns about leaving familiar paediatric healthcare environments and establishing relationships with new healthcare professionals. Post‐transfer patients described increased responsibility for managing their healthcare and recognised the challenges associated with greater autonomy; however, they generally reported satisfaction with adult care despite initial concerns. Parents worried about losing involvement in their child's care and feared reduced emotional support and lower‐quality care after transfer. Across all groups, participants emphasised the emotional and practical adjustments required during the transition, particularly the need to establish new relationships with healthcare providers. Suggested improvements included clearer communication, written information and better preparation regarding the differences between paediatric and adult care. Conclusions: Transition from paediatric to adult care in IBD involves emotional, relational and practical challenges for both patients and parents. Structured transition pathways, clear communication and adequate preparation may facilitate continuity of care and support the development of autonomy. Although most participants reported positive experiences after transfer, further research is needed to determine how adult healthcare services can best support young adults with IBD and optimise long‐term transition outcomes.

  • Open Access

    Polyp prophylactic properties of polyacetylenes from carrots in patients with previous polypectomy—Px7 The study protocol of a multicentre binational randomised controlled trial

    by Alexandra Agache, Ulrik Deding, Lasse Kaalby, Morten Kobaek-Larsen, Issam Al-Najami, Lea Østergaard Hansen, Camilla Stryhn, Danielle Wilde, Anna Forsberg, Ann-Sofie Backman, et al.

    Introduction: A large bowel cancer chemoprevention potential has been demonstrated by the consumption of carrots, which represent the major dietary source of polyacetylenes. Their interaction with cancer cells and enzyme systems of animals and humans has been systematically investigated over the last 15 years and has now been characterised as anti-inflammatory compounds with antineoplastic effect. Our objective is to investigate whether selected carrot species with a high content of the polyacetylenes falcarinol (FaOH) and falcarindiol (FaDOH) prevent neoplastic transformation and growth in humans, without side effects. Methods and analysis: We will conduct a multicentre prospective binational (Denmark and Sweden) randomised controlled trial, with the aim to test the clinical effects of adjuvant treatment with carrot juice in patients who had an excision of high-risk colon adenomas. Patients from six centres will be randomised to receive either anti-inflammatory juice made of carrots high in FaOH and FaDOH or placebo. We will compare the proportion of participants with recurrent adenoma and mean size of them, found in the 1-year follow-up colonoscopy between the two randomised groups. Ethics and dissemination: Informed written consent will be obtained from all participants before randomisation. The study was approved by the regional ethics committee in Denmark (ref. S-20230072) and Sweden (ref. 2024-04732-01 ). After completion of the trial, we plan to publish two articles in high-impact journals: one article on primary and secondary outcomes, respectively. Trial registration number: NCT06335420 .

  • Open Access

    Mesalamine for Colorectal Cancer Prevention Programme in Lynch syndrome (MesaCAPP): a multicentre, multinational, randomised, two-arm, double-blind, phase II clinical study with mesalamine or placebo in carriers with Lynch syndrome – a study protocol

    by Ann-Sofie Backman, Alexander Frank, Lars Joachim Lindberg, David Ljungman, Gustav Silander, Rita J Gustafsson, Tünde Bozsó, Peter T Schmidt, Michael Ingre, Martina Mittlbock, et al.

    Introduction: Lynch syndrome (LS) carriers have a 20–46% lifetime risk of colorectal cancer (CRC) due to mismatch repair gene variants. Mesalamine (5-ASA, 5-aminosalicylic acid), used safely in patients with ulcerative colitis, may reduce CRC risk in LS by decreasing microsatellite instability, a key driver of LS-related cancer. This study evaluates 5-ASA’s efficacy as a tolerable chemopreventive drug, aiming to improve long-term CRC prevention in LS. Methods and analysis: This multicentre, multinational, randomised, double-blind, two-arm, phase II clinical study will compare the effects of a 2-year daily intake of 5-ASA (2000 mg) to placebo in LS carriers. The primary objective is to assess whether mesalamine reduces colorectal neoplasia, both benign and malignant, compared with placebo in LS carriers, as detected by colonoscopy at the end of the treatment period (24 months±1 month) and on study completion. Secondary objectives include evaluating whether 5-ASA reduces neoplasia/tumour multiplicity and progression compared with placebo at specified time points, examining variations in the effects of 5-ASA versus placebo based on cancer history, sex and age (<45 years vs ≥45 years), and assessing the safety of 5-ASA in LS carriers. Ethics and dissemination: The trial is currently open for enrolment, having received ethical approval from the Regional Ethical Review Board in Stockholm and funding from the Swedish Research Council. The study protocol is the finalised V.10.0 (11 April 2024), transitioned to the European Clinical Trials Information System. LS remains underdiagnosed, which may limit recruitment. The results are of global interest and will be published in peer-reviewed journals and presented at scientific conferences. Trial registration number: ClinicalTrials.gov: NCT04920149 . EudraCT: 2019-003011-55. EU CT: 2024-514765-19-01.

  • Open Access

    Complications of colonoscopy surveillance of patients with Lynch syndrome – 33 years of follow up

    by Alexander Frank, Sophie Walton Bernstedt, Nigin Jamizadeh, Anna Forsberg, Charlotte Hedin, Johannes Blom, Ann-Sofie Backman

    Background and study aims: Lynch syndrome (LS) is a hereditary autosomal dominant condition, with an increased lifetime risk of developing malignancies including colorectal cancer (CRC). Current guidelines differ in recommended colonoscopy-surveillance intervals from 1 to 2 years. Although colonoscopy is considered a safe procedure, there are risks of severe adverse events (SAEs), such as perforation and bleeding, as well as adverse events (AEs), such as abdominal discomfort and post-colonoscopy gastrointestinal infections. Colonoscopy-related bleeding and perforation rates have been reported 0.17% and 0.11%, respectively. However, there are insufficient data regarding complications of colonoscopy-surveillance for LS patients. This study aims to investigate the risk of AEs among LS patients during colonoscopy in the Stockholm region. Patients and methods: This retrospective cohort study includes 351 LS patients undergoing endoscopic surveillance at the Karolinska University Hospital, August 1989 – April 2021. Data from endoscopic surveillance colonoscopies were extracted from patients’ medical records. Results: Of 1873 endoscopies in 351 LS patients, 12 complications (AEs) were documented within 30 days (0.64%) and with a total of 3 bleedings (SAEs, 0.16%). No perforations were identified. Conclusion: Colonoscopy surveillance for LS patients shows a comparatively low risk of AEs per-examination. Colonoscopy complications per-patient, including both SAEs and AEs, show a significantly higher risk. Colonoscopy complications only including SAEs, show a comparatively low risk. Understanding the lifetime risk of surveillance-related colonoscopy complications is important when designing targeted surveillance programmes.


  • Open Access

    Quality of endoscopic surveillance of Lynch syndrome patients in a Swedish cohort

    by Sophie Walton Bernstedt, Adrianna Haxhijaj, Nigin Jamizadeh, Jan Björk, Anna Andreasson, Anna M Forsberg, Ann-Sofie Backman

    Background and study aims Risk factors for colorectal cancer (CRC) in Lynch syndrome (LS) include sex, age, smoking, high body mass index (BMI), surveillance interval length, and risk genotype. The Boston Bowel Preparation Scale (BBPS) produces a standardized bowel cleanliness rating. A low BBPS score might be a risk factor for missed early lesions. The aim of this study was to investigate the correlation between BBPS score and adenoma detection (with known risk factors for CRC) and surveillance interval with CRC detection in LS patients. Methods A retrospective cohort study including 366 LS patients with 1,887 colonoscopies under surveillance in Stockholm, Sweden from 1989 to 2021 was conducted. Associations were tested using linear and logistic regression. Results We found no association between BBPS score and number of adenomas detected. A low BBPS score was found to be associated with older age (regression coefficient (coeff) –0.015; 95% confidence interval [CI] –0.026 to –0.004; P = 0.007) and obesity (coeff = –0.48; 95% CI: –0.89 to –0.062; P = 0.024). A higher number of detected adenomas was associated with older age (coeff = 0.008; 95% CI 0.004 to 0.012; P < 0.001), male sex (coeff = 0.097; 95% CI 0.008 to 0.19; P = 0.033) and CRC (coeff = 0.28; 95% CI 0.061 to 0.50; P = 0.012). Surveillance interval length was not significant in CRC detection. Conclusions Bowel cleanliness was not associated with adenoma detection and was less likely achieved in patients who were older and had higher BMI. Adenoma detection was associated with older age and male sex. The results indicate the need for better adherence to guidelines and attention to older age groups, men, and patients with obesity.


  • Open Access

    Endoscopic surveillance of Lynch syndrome at a highly specialized center in Sweden: An observational study of interval colorectal cancer and individual risk factors

    by Nigin Jamizadeh, Sophie Walton Bernstedt, Adrianna Haxhijaj, Anna Andreasson, Jan Björk, Anna Forsberg, Ann-Sofie Backman

    Introduction: Lynch syndrome (LS) is the most common hereditary cause of colorectal cancer (CRC). In order to detect CRCs amongst LS patients, regular colonoscopies are recommended. However, an international agreement on an optimal surveillance interval has not yet been reached. In addition, few studies have investigated factors that could potentially increase the CRC risk amongst LS patients.Aims: The primary aim was to describe the frequency of CRCs detected during endoscopic surveillance and to estimate the interval from a clean colonoscopy to CRC detection amongst LS patients. The secondary aim was to investigate individual risk factors, including sex, LS genotype, smoking, aspirin use and body mass index (BMI), on CRC risk amongst patients that develop CRC before and during surveillance.Material and methods: Clinical data and colonoscopy findings from 366 LS patients’ 1437 surveillance colonoscopies were collected from medical records and patient protocols. Logistic regression and Fisher’s exact test were used to investigate associations between individual risk factors and CRC development. Mann-Whitney U test was used to compare the distribution of TNM stages of CRC detected before surveillance and after index.Results: CRC was detected in 80 patients before surveillance and in 28 patients during surveillance (10 at index and 18 after index). During the surveillance programme, CRC was detected within 24 months in 65% of the patients, and after 24 months within 35% of the patients. CRC was more common amongst men, previous and current smokers, and the odds of developing CRC also increased with an increasing BMI. CRCs were more often detected amongst MLH1 and MSH2 carriers during surveillance, compared to the other genotypes.Conclusions: We found that 35% of the CRC cases detected during surveillance were found after 24 months. MLH1 and MSH2 carriers were at higher risk of developing CRC during surveillance. Additionally, men, current or previous smokers, and patients with a higher BMI were at higher risk of developing CRC. Currently, LS patients are recommended a “one-size-fits-all” surveillance program. The results support the development of a risk-score whereby individual risk factors should be taken into consideration when deciding on an optimal surveillance interval.


  • Open Access

    Room for improvement: One third of Lynch syndrome patients presenting for genetic testing in a highly specialised centre in Stockholm already have cancer

    by Sophie Walton Bernstedt, Jan Björk, Kaisa Fritzell, Allan D. Spigelman, Erik Björck, Ann-Sofie Backman

    Background: Lynch syndrome is caused by germline mutations in the mismatch repair genes and is characterised by a familial accumulation of colorectal and other cancers. Earlier identification of Lynch syndrome patients enables surveillance and might reduce the risk of cancer. It is important to explore whether today’s clinical care discovers patients with Lynch syndrome suitable for surveillance in time. This study aimed to describe what led to a diagnosis of Lynch syndrome in the cohort referred to the Hereditary Gastrointestinal Cancer Unit, Karolinska University Hospital, Solna, Sweden for gastrointestinal surveillance. Methods: This was a descriptive study. Data from 1975 to 2018 were collected and compiled as a database. Age at diagnosis was calculated from the date when a pathogenic MMR gene mutation was confirmed, from the period June 1994–September 2018. Data were collected from patient protocols prospectively during patient consultations and medical records retrospectively. Criteria for inclusion were registration at the outpatient clinic and a confirmed mismatch repair gene mutation. Results: A total of 305 patients were eligible for inclusion. Three major reasons for diagnosis were identified: 1. Predictive testing of a previously known mutation in the family (62%, mean age 37), 2. A family history of Lynch associated tumours (9%, mean age 37), 3. A diagnosis of cancer (29%, mean age 51). The proportion diagnosed due to cancer has not changed over time. Conclusion: A high proportion of patients (29%) were identified with Lynch syndrome after they had been diagnosed with an associated cancer, which suggests that there is significant room for improvement in the diagnosis of patients with Lynch syndrome before cancer develops.


  • Use of healthcare information and advice among non-urgent patients visiting emergency department or primary care

    by Ann-Sofie Backman, Magdalena Lagerlund, Tobias Svensson, Paul Blomqvist, Johanna Adami

    Background Healthcare information provided by telephone service and internet sources is growing but has not been shown to reduce inappropriate emergency department (ED) visits. Objective To describe the use of advice or healthcare information among patients with non-urgent illnesses seeking care before attendance at an ED, or primary care (PC) centres in an urban region in Sweden. Design Patients with non-urgent illnesses seeking care at an ED or patients attending the PC were followed up with a combination of patient interviews, a questionnaire to the treating physician and a prospective follow-up of healthcare use through a population-based registry. Results Half of the non-urgent patients attending the ED had used healthcare information or advice before the visit, mainly from a healthcare professional source. In PC, men were more likely to have used information or advice compared with women (OR 2.5 95% CI 1.3 to 5.0), whereas the situation was reversed among ED patients (OR=0.4 95% CI 0.2 to 0.9). Men with no previous healthcare experience attending the ED had the lowest use of healthcare information (pConclusion ED patients rated as non-urgent by the triage nurse used more advice and healthcare information than PC patients, irrespective of the physician-rated urgency of the symptoms. The problem seems not to be lack of information about appropriate ED use, but to find ways to direct the information to the right target group.


  • Health care utilization following a non-urgent visit in emergency department and primary care

    by Ann-Sofie Backman, Paul Blomqvist, Tobias Svensson, Johanna Adami

    Unscheduled visits to an emergency department (ED) or to primary care (PC) are often followed by further healthcare contacts. Present knowledge about predisposing factors and differences between healthcare levels is sparse. The objectives of this study were to describe and to analyze factors influencing subsequent healthcare contacts within 30 days following a non-urgent ED visit or an unscheduled visit in PC. In this prospective cohort study, subjects were identified and interviewed at the time of a non-urgent ED visit or unscheduled visits to PC. Data of all healthcare contacts during 1 month were collected. The probability of reattendance was analyzed regarding socio-demographic factors, previous and present health care utilization, the physicians’ perceptions of the urgency of the visit, and appropriateness of its level of care. More than half of the patients in both settings had at least one contact with healthcare the following month. In 16% of the ED patients and 9% of PC patients, these contacts were to an ED. In the multivariate analysis, patients with regular monitoring of chronic disease were associated with an increased probability of having one or more physician visit the following month (OR 1.97 CI 95% 1.15–3.36). In conclusion, previous health care utilization was associated with an increased probability of one or more further physician visits the following month, regardless of the setting for the index visit or other patients characteristics. Physicians’ perception of urgency did not influence the probability of further contacts.